Communication practices and awareness of resources for acromegaly patients among endocrinologists

References

• MelmedSMedical progress: acromegalyN Engl J Med2006355242558257317167139
   PubMed Web of Science ®Google Scholar
• MelmedSAcromegaly pathogenesis and treatmentJ Clin Invest2009119113189320219884662
   PubMed Web of Science ®Google Scholar
• RowlesSVPrietoLBadiaXShaletSMWebbSMTrainerPJQuality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaireJ Clin Endocrinol Metab20059063337334115755865
   PubMed Web of Science ®Google Scholar
• StrasburgerCJKaravitakiNStormannSPatient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegalyEur J Endocrinol2016174335536226744896
   PubMed Web of Science ®Google Scholar
• ColaoAFeroneDMarzulloPLombardiGSystemic complications of acromegaly: epidemiology, pathogenesis, and managementEndocr Rev200425110215214769829
   PubMed Web of Science ®Google Scholar
• MelmedSCasanuevaFFKlibanskiAA consensus on the diagnosis and treatment of acromegaly complicationsPituitary201316329430222903574
   PubMed Web of Science ®Google Scholar
• PlaczekHXuYMuYBegelmanSMFisherMClinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysisJ Manag Care Spec Pharm201521121106111226679960
   PubMed Web of Science ®Google Scholar
• BroderMSNearyMPChangECherepanovDKatznelsonLTreatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databasesPituitary201417433334124037646
   PubMed Web of Science ®Google Scholar
• AuriemmaRSGaldieroMDe MartinoMCThe kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remissionEur J Endocrinol201016261035104220356933
   PubMed Web of Science ®Google Scholar
• AdelmanDTLiebertKJPNachtigallLBLamersonMBakkerBAcromegaly: the disease, its impact on patients, and managing the burden of long-term treatmentInt J Gen Med20136313823359786
   PubMedGoogle Scholar
• DekkersOMBiermaszNRPereiraAMRomijnJAVandenbrouckeJPMortality in acromegaly: a metaanalysisJ Clin Endocrinol Metab2008931616717971431
   PubMed Web of Science ®Google Scholar
• HoldawayIMRajasooryaRCGambleGDFactors influencing mortality in acromegalyJ Clin Endocrinol Metab200489266767414764779
   PubMed Web of Science ®Google Scholar
• KatznelsonLLawsERJrMelmedSAcromegaly: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab201499113933395125356808
   PubMed Web of Science ®Google Scholar
• HoldawayIMBollandMJGambleGDA meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegalyEur J Endocrinol20081592899518524797
   PubMed Web of Science ®Google Scholar
• Ben-ShlomoASheppardMCStephensJMPulgarSMelmedSClinical, quality of life, and economic value of acromegaly disease controlPituitary201114328429421597975
   PubMed Web of Science ®Google Scholar
• KasukiLMarquesNVNuezMJLealVLChinenRNGadelhaMRAcromegalic patients lost to follow-up: a pilot studyPituitary201316224525022821645
   PubMed Web of Science ®Google Scholar
• GurelMHBrueningPRRhodesCLomaxKGPatient perspectives on the impact of acromegaly: results from individual and group interviewsPatient Prefer Adherence20148536224453479
   PubMedGoogle Scholar
• PlunkettCBarkanALThe care continuum in acromegaly: how patients, nurses, and physicians can collaborate for successful treatment experiencesPatient Prefer Adherence201591093109926251582
   PubMed Web of Science ®Google Scholar
• Council of American Survey Research OrganizationsCASRO^® Available from: http://www.casro.org/?page=TheCASROCode2014Accessed September 29, 2016
   Google Scholar
• BurtonTLeNEBancroftTNearyMReal-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databasesPituitary201316335436223054327
   PubMed Web of Science ®Google Scholar
• BroderMSChangELudlamWHNearyMPCarmichaelJDPatterns of pharmacologic treatment in US patients with acromegalyCurr Med Res Opin201632579980526609770
   PubMed Web of Science ®Google Scholar
• SchoflCGrussendorfMHoneggerJFailure to achieve disease control in acromegaly: cause analysis by a registry-based surveyEur J Endocrinol2015172435135625599707
   PubMed Web of Science ®Google Scholar
• SilversteinJMNeed for improved monitoring in patients with acromegalyEndocrine Connections201544R59R6726381160
   PubMed Web of Science ®Google Scholar
• DelemerBChansonPFoubertLPatients lost to follow-up in acromegaly: results of the ACROSPECT studyEur J Endocrinol2014170579179724591552
   PubMed Web of Science ®Google Scholar
• DiMatteoMRGiordaniPJLepperHSCroghanTWPatient adherence and medical treatment outcomes: a meta-analysisMed Care200240979481112218770
   PubMed Web of Science ®Google Scholar
• AyyagariRWeiWChengDPanCSignorovitchJWuEQEffect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatmentValue Health201518219820525773555
   PubMed Web of Science ®Google Scholar
• BluettJMorganCThurstonLImpact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortRheumatology201554349449925213131
   PubMed Web of Science ®Google Scholar
• BarnesCBUlrikCSAsthma and adherence to inhaled corticosteroids: current status and future perspectivesRespir Care201560345546825118311
   PubMed Web of Science ®Google Scholar
• CohenBACoylePKLeistTOleen-BurkeyMASchwartzMZwibelHTherapy optimization in multiple sclerosis: a cohort study of therapy adherence and risk of relapseMult Scler Relat Disord201541758225787057
   PubMed Web of Science ®Google Scholar
• De VeraMABholeVBurnsLCLacailleDImpact of statin adherence on cardiovascular disease and mortality outcomes: a systematic reviewBr J Clin Pharmacol201478468469825364801
   PubMed Web of Science ®Google Scholar
• MenzinJCaonCNicholsCWhiteLAFriedmanMPillMWNarrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJ Manag Care Pharm2013191 Suppl AS24S4023383731
   PubMed Web of Science ®Google Scholar
• LiuSXuYBegelmanSMShiLBarriers to treatment adherence associated with acromegaly in the United States: provider’s perspectiveValue Health2015183A64
   Web of Science ®Google Scholar
• ZolnierekKBDiMatteoMRPhysician communication and patient adherence to treatment: a meta-analysisMed Care200947882683419584762
   PubMed Web of Science ®Google Scholar
• VermeireEHearnshawHVan RoyenPDenekensJPatient adherence to treatment: three decades of research. A comprehensive reviewJ Clin Pharmacol2001265331342
   Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar